With the help of clinical and biochemical tests, we will evaluate the relative benefits of Terlipressin in combination with albumin against albumin alone for treating hepatorenal syndrome. The eighty patients were divided evenly. Albumin was the sole treatment for Group 1, whereas Terlipressin was added to the mix for Group 2. The information was analysed with IBM SPSS 20. The tables were made using a combination of a frequency distribution and a crosstabulation.